SCHEMBL124804

SCHEMBL124804

CN1CCSCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13174225 0.96 INMT (0.33)
SCHEMBL7208434 0.96 INMT (0.33)
SCHEMBL13174086 0.96 INMT (0.33)
SCHEMBL12039647 0.96 INMT (0.33)
SCHEMBL2184351 0.87
SCHEMBL15094238 0.87 INMT (0.30)
SCHEMBL24681421 0.85
SCHEMBL28550749 0.85
SCHEMBL17530849 0.83 CA12 (0.35)
SCHEMBL24962137 0.81 CYP1A2 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3624 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118515627-A Continuous synthesis method of deuterated heterocyclic compound and catalyst fixed bed system 安徽泽升科技股份有限公司 2024-08-20 CN claimed
US-20230146395-A1 Substituted Pyrimidines and Uses Thereof Verge Analytics, Inc. (US) 2023-05-11 US claimed
EP-4118087-A1 SUBSTITUTED FURO[3,2-D]PYRIMIDINES AND USES THEREOF Verge Analytics, Inc. (US) 2023-01-18 EP claimed
WO-2022261068-A1 METHODS AND TREATMENT OF VIRAL INFECTION WITH SUBSTITUTED FURO-PYRIMIDINES Verge Analytics, Inc. (US) 2022-12-15 WO claimed
WO-2021183439-A1 SUBSTITUTED FURO[3,2-D]PYRIMIDINES AND USES THEREOF Verge Analytics, Inc. (US) 2021-09-16 WO claimed
CN-111718332-B 2-substituted pyrazol amino-4-substituted amino-5-pyrimidine formamide compound, composition and application thereof 北京赛特明强医药科技有限公司 2021-08-17 CN claimed
CN-111718332-A 2-substituted pyrazol amino-4-substituted amino-5-pyrimidine formamide compound, composition and application thereof 北京赛特明强医药科技有限公司 2020-09-29 CN claimed
US-10201525-B2 Tetrazole-substituted arylamides as PX2 and PX2/3 antagonists ROCHE PALO ALTO LLC (US) 2019-02-12 US claimed
EP-2976339-B1 GEMINALLY SUBSTITUTED CYANOETHYLPYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS MERCK SHARP & DOHME (US) 2018-06-27 EP claimed
US-9957264-B2 Geminally substituted cyanoethylpyrazolo pyridones as Janus kinase inhibitors MERCK SHARP & DOHME CORP. (US) 2018-05-01 US claimed
EP-0604368-A1 Anti retroviral hydrazine derivatives CIBA-GEIGY AG (CH) 1994-06-29 EP claimed
US-5312459-A Nitrogen additives to fuel SPRUGEL FRIEDRICH A 1994-05-17 US claimed
EP-0594540-A1 Antiretroviral acyl compounds CIBA-GEIGY AG (CH) 1994-04-27 EP claimed
WO-1992022545-A1 NEW COUMARIN DERIVATIVES FIDIA S.P.A. (IT) 1992-12-23 WO claimed
EP-0410202-B1 ADDITIVE FOR LIQUIFIEDGAS-FUEL Sprügel, Friedrich (DE) 1992-09-30 EP claimed
US-5028693-A Preparation of polypeptides, fewer by-products BIORESEARCH, INC. (US) 1991-07-02 US claimed
EP-0410202-A1 Additive for liquifiedgas-fuel Sprügel, Friedrich (DE) 1991-01-30 EP claimed
EP-0401093-A1 Pyrrolidone derivatives, process for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1990-12-05 EP claimed
EP-0385038-A1 Ortho-substituted phenyl amidine and phenyl guanidine derivatives and antidiabetic or hypoglycaemic agents containing them The Boots Company PLC (GB) 1990-09-05 EP claimed
US-4016263-A BACTERICIDES BOEHRINGER INGELHEIM GMBH (DT) 1977-04-05 US claimed